- Save article
NewsGlaxoSmithKline schemes offload annuity risk to Prudential
UK – Two of GlaxoSmithKline's pension plans have offloaded some of their annuity risk by entering into bulk annuity contracts with Prudential.
- Save articleNews
GlaxoSmithKline consolidates €6bn custody
EUROPE - Pharmaceutical giant GlaxoSmithKline has consolidated €6bn in custody with ABN Amro Mellon, according to the provider.
- Save articleNews
GlaxoSmithKline looking at managers in revamp
UK - Pharmaceutical giant GlaxoSmithKline says it is "looking at managers" as it combines more than £4bn (€5.8bn) in pension assets.
- Save articleNews
People moves: GSK appoints UK pensions chief; LSR names new CEO [updated]
GlaxoSmithKline, LSR, Columbia Threadneedle, WTW, Gresham House, AXA IM, Aon, ICG, Smart Pension, Cairn Capital, XPS, Achmea, AFM, Northern Trust, SYZ AM, Morningstar, PIMCO
- Save article
News‘World’s first’ nature targets unveiled in bumper week for natural capital developments
Guidance for entities wishing to start setting nature-related targets was launched by the Science Based Targets Network
- Save articleNews
Institutional investors submit healthy foods resolution at Unilever
GMPF, Actiam, Candriam among co-filers
- Save articleNews
ESG roundup: Unilever shareholder campaign claims transparency win
Plus: Corporates lacking on climate transition plans; Climate-nature ‘integrated transition framework’; Data availability struggles
- Save article
Special ReportUK: Labour government seeks continuity with focus on boosting domestic investment
The Department for Work and Pensions will have its work cut out as the new Labour government starts a comprehensive pensions review
- Save article
NewsUK MPs criticise government over handling of FRC chair appointment
Simon Dingemans is set to chair the Financial Reporting Council and its successor body – but politicians have expressed ‘frustration and dissatisfaction’ at the process
Asset Manager NewsPATRIZIA wins EUR 180 million fund management mandate in Italy
PATRIZIA Immobilien AG, the global partner for pan-European real estate investment, has secured a fund management mandate in Italy from Fondazione Cariverona – one of the most important Italian bank foundations and founder of UNICREDIT Bank. Verona Property is an Italian real estate fund with assets under management (AUM) of EUR 180 million. It will be managed on behalf of the institutional investor, Fondazione Cariverona, with the aim of unlocking value from the current assets and ultimately recycling capital to deliver a more diversified real estate portfolio.
- Save articleNews
Avon takes the lead in Glaxo class action
[16:30 CEST 10-10] UK – Avon Pension Fund has been accepted as the lead plaintiff in a US securities class action suit against pharmaceutical giant GlaxoSmithKline.
- Save articleNews
Lay trustee role increasingly difficult to sustain, industry says
The role has changed significantly in recent years due to increased governance requirements
- Save article
Opinion PiecesHealthcare investing: Get ready for the next pandemic
The world will have to collaborate on many fronts to ensure preparedness for the next global health crisis.
- Save article
Special ReportUK: Encouraging UK growth through consolidation
The UK government is pursuing plans to leverage pension assets to boost economic growth while generating best returns for members
- Save articleNews
CalPERS pressures Glaxo on AIDS drugs
US – CalPERS, the US’s largest pension fund, is writing to GlaxoSmithKline urging the UK pharmaceutical company to re-evaluate its policy on AIDS drugs.
- Save articleNews
Pharma major hires Mercer for DC review
[16:30 CEST 01-08] UK – Pharmaceuticals giant GlaxoSmithKline (GSK) has hired Mercer Human Resource Consulting to review the design and investment strategy of its £850m (€1.3bn) UK-based defined contribution (DC) plan.
- Save articleNews
Avon and North Yorks file GSK class action
[13:15 CEST 14-09] UK – Avon and North Yorkshire county council pension funds are filing legal papers in the US to lead a class action suit against GlaxoSmithKline for allegedly misleading the stock market about the safety of one of its drugs.
Asset Manager NewsEuropean equities – the best option for resilient income
With bond markets offering little in the way of income, the continent’s highest quality equities offer an attractive and defensive yield
- Save articleNews
Institutions flex muscles in Glaxo pay vote
UK – Shareholders have voted to reject a controversial pay package of the chief executive of drugs company GlaxoSmithKline - the first time a UK blue-chip company has had its pay scheme rejected by shareholders.
Asset Manager NewsPharmaceutical companies in a golden age for drug discovery
As new technologies such as genomics spur development of innovative drugs, European pharmaceuticals companies stand out as high-quality, defensive growth stocks
Search results
Copyright © 1997–2025 IPE International Publishers Limited, Registered in England, Reg No. 3233596, VAT No. 685 1784 92. Registered Office: 1 Kentish Buildings, 125 Borough High Street, London SE1 1NP
Site powered by Webvision Cloud